What do payers think about prior authorization? Dr. Andrew Hertler is Chief Medical Officer at <a href="https://www.evolent.com/leadership/andrew-hertler-md" target="_blank">Evolent Health</a>. He recently co-authored an <a href="https://ascopost.com/issues/june-10-2023/rethinking-prior-authorization/" target="_blank">op-ed about prior authorization</a>, touching on gold-carding, a controversial solution to addressing prior authorization challenges. Joining Hertler is regular guest <a href="https://www.linkedin.com/in/john-hennessy-4a62921/" target="_blank">John Hennessy</a>, a Principal with Valuate. Topics include:<ul><li>Why exceptions can sometimes be problematic.</li><li>What happens after a prior authorization is rejected.</li><li>Pathways: Who makes the decisions? How are they updated?</li><li>How should pharma  think about payers?</li><li>What can manufacturers and market access do to help pathways?</li></ul>Follow Andrew on  <a href="https://www.linkedin.com/in/andrew-hertler-md-facp-41b793159/" target="_blank">LinkedIn</a>. Follow Valuate on <a href="https://www.linkedin.com/company/valuate-health-consultancy/" target="_blank">LinkedIn</a><a href="https://theidi.simplecast.com/episodes/www.ValuateHealth.com" target="_blank">Learn more</a> about Valuate.

Social Determinants of Health and Market Access

The IDI is a podcast by and for market access professionals. Each episode, we conduct in-depth interviews to get payer insights that help you optimize your value strategy and commercialization – and give people access to the heath care they deserve.	 

The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.